Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

October 1, 2022; Volume 63,Issue 10

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 10A;

Discussions with Leaders

  • You have access
    Integrating Nuclear Imaging and Cardiology in Clinical Practice
    Jeroen J. Bax and Frank M. Bengel
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1455-1458; DOI: https://doi.org/10.2967/jnumed.122.264806

The State of the Art

  • You have access
    Single-Cell Radiotracer Allocation via Immunomagnetic Sorting to Disentangle PET Signals at Cellular Resolution
    Laura M. Bartos, Sebastian T. Kunte, Philipp Beumers, Xianyuan Xiang, Karin Wind, Sibylle Ziegler, Peter Bartenstein, Hongyoon Choi, Dong Soo Lee, Christian Haass, Louisa von Baumgarten, Sabina Tahirovic, Nathalie L. Albert, Simon Lindner and Matthias Brendel
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1459-1462; DOI: https://doi.org/10.2967/jnumed.122.264171

Hot Topics

  • You have access
    α-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet?
    John P. Seibyl
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1463-1466; DOI: https://doi.org/10.2967/jnumed.122.263918

Continuing Education

  • You have access
    Dosimetry in Radiopharmaceutical Therapy
    Joe O’Donoghue, Pat Zanzonico, John Humm and Adam Kesner
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1467-1474; DOI: https://doi.org/10.2967/jnumed.121.262305

Focus on Molecular Imaging

  • You have access
    Single-Domain Antibody Theranostics on the Horizon
    Weijun Wei, Muhsin H. Younis, Xiaoli Lan, Jianjun Liu and Weibo Cai
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1475-1479; DOI: https://doi.org/10.2967/jnumed.122.263907

Editorial

  • You have access
    Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer: We Have the Answers
    Kelsey L. Pomykala, Ken Herrmann, Anwar R. Padhani, Michael S. Hofman, Elisabetta Lalumera and Stefano Fanti
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1480-1481; DOI: https://doi.org/10.2967/jnumed.122.264394

Theranostics

  • Clinical

    • INVITED PERSPECTIVE

      • You have access
        Outcome of Patients with PSMA PET/CT Screening Failure by VISION Criteria and Treated with 177Lu-PSMA: A Multicenter Retrospective Analysis
        Oliver Sartor
        Journal of Nuclear Medicine October 1, 2022, 63 (10) 1482-1483; DOI: https://doi.org/10.2967/jnumed.122.264128
    • BRIEF COMMUNICATION

      • Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with <sup>177</sup>Lu-PSMA Therapy: A Multicenter Retrospective Analysis
        You have access
        Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with 177Lu-PSMA Therapy: A Multicenter Retrospective Analysis
        Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais
        Journal of Nuclear Medicine October 1, 2022, 63 (10) 1484-1488; DOI: https://doi.org/10.2967/jnumed.121.263441
    • Synthesis and Preclinical Evaluation of <sup>177</sup>Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
      Open Access
      Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
      Alexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, Veronika Felber, Roswitha Beck, Francesco de Rose, Calogero D’Alessandria, Wolfgang Weber and Hans-Jürgen Wester
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1489-1495; DOI: https://doi.org/10.2967/jnumed.121.263371
    • FEATURED ARTICLE OF THE MONTH

      • mCRPC Patients Receiving <sup>225</sup>Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis
        Open Access
        mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis
        Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, Ismaheel O. Lawal, Otto Knoesen, Johncy Mahapane, Cindy Davis, Amanda Mdlophane, Alex Maes, Kgomotso Mokoala, Kgomotso Mathabe, Christophe Van, de Wiele and Alfred Morgenstern
        Journal of Nuclear Medicine October 1, 2022, 63 (10) 1496-1502; DOI: https://doi.org/10.2967/jnumed.121.263618
    • Safety of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumor Patients with Chronic Kidney Disease
      You have access
      Safety of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients with Chronic Kidney Disease
      Shahad Alsadik, Gopinath Gnanasegaran, Luohai Chen, Dalvinder Mandair, Christos Toumpanakis, Martyn Caplin and Shaunak Navalkissoor
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1503-1508; DOI: https://doi.org/10.2967/jnumed.121.263056
    • Heterogeneity of SSTR2 Expression Assessed by <sup>68</sup>Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors
      You have access
      Heterogeneity of SSTR2 Expression Assessed by 68Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors
      Rosa Fonti, Mariarosaria Panico, Sara Pellegrino, Alessandro Pulcrano, Luisa Alessia Vastarella, Armin Hakkak Moghadam Torbati, Mario Giuliano, Giovannella Palmieri, Sabino De Placido and Silvana Del Vecchio
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1509-1514; DOI: https://doi.org/10.2967/jnumed.121.262928

Oncology

  • Clinical

    • Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with <sup>131</sup>I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
      Open Access
      Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with 131I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
      Alberto Signore, Giuseppe Campagna, Jessica Marinaccio, Marco de Vitis, Chiara Lauri, Francesco Berardinelli, Anna Tofani, Marco Chianelli, Marina Borro, Giovanna Gentile, Maurizio Simmaco, Francesco Colombini, Anna Giovanetti and Antonella Sgura
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1515-1522; DOI: https://doi.org/10.2967/jnumed.121.263442
    • <sup>89</sup>Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
      You have access
      89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
      Sarah R. Verhoeff, Pim P. van de Donk, Erik H.J.G. Aarntzen, Sjoukje F. Oosting, Adrienne H. Brouwers, Iris H.C. Miedema, Jens Voortman, Willemien C. Menke-van der Houven van Oordt, Ronald Boellaard, Dennis Vriens, Marije Slingerland, Rick Hermsen, Ilse van Engen-van Grunsven, Sandra Heskamp and Carla M.L. van Herpen
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1523-1530; DOI: https://doi.org/10.2967/jnumed.121.263470
    • Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
      You have access
      Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
      Marinus J. Hagens, Daniela E. Oprea-Lager, André N. Vis, Maurits Wondergem, Maarten L. Donswijk, Dennie Meijer, Louise Emmett, Pim J. van Leeuwen and Henk G. van der Poel
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1531-1536; DOI: https://doi.org/10.2967/jnumed.121.263139
    • <sup>18</sup>F-PFPN PET: A New and Attractive Imaging Modality for Patients with Malignant Melanoma
      You have access
      18F-PFPN PET: A New and Attractive Imaging Modality for Patients with Malignant Melanoma
      Xiao Zhang, Mengting Li, Yongkang Gai, Jing Chen, Juan Tao, Liu Yang, Fan Hu, Wenyu Song, Tzu-Chen Yen and Xiaoli Lan
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1537-1543; DOI: https://doi.org/10.2967/jnumed.121.263179

Radionuclide Therapy

  • Clinical

    • <sup>223</sup>Ra Induces Transient Functional Bone Marrow Toxicity
      You have access
      223Ra Induces Transient Functional Bone Marrow Toxicity
      Maria Parlani, Francesco Boccalatte, Anna Yeaton, Feng Wang, Jianhua Zhang, Iannis Aifantis and Eleonora Dondossola
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1544-1550; DOI: https://doi.org/10.2967/jnumed.121.263310

Neurology

  • Clinical

    • First-in-Humans Evaluation of <sup>18</sup>F-SMBT-1, a Novel <sup>18</sup>F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis
      You have access
      First-in-Humans Evaluation of 18F-SMBT-1, a Novel 18F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis
      Victor L. Villemagne, Ryuichi Harada, Vincent Doré, Shozo Furumoto, Rachel Mulligan, Yukitsuka Kudo, Samantha Burnham, Natasha Krishnadas, Svetlana Bozinovski, Kun Huang, Brian J. Lopresti, Kazuhiko Yanai, Christopher C. Rowe and Nobuyuki Okamura
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1551-1559; DOI: https://doi.org/10.2967/jnumed.121.263254
    • Assessing Reactive Astrogliosis with <sup>18</sup>F-SMBT-1 Across the Alzheimer Disease Spectrum
      You have access
      Assessing Reactive Astrogliosis with 18F-SMBT-1 Across the Alzheimer Disease Spectrum
      Victor L. Villemagne, Ryuichi Harada, Vincent Doré, Shozo Furumoto, Rachel Mulligan, Yukitsuka Kudo, Samantha Burnham, Natasha Krishnadas, Pierrick Bourgeat, Ying Xia, Simon Laws, Svetlana Bozinovski, Kun Huang, Milos D. Ikonomovic, Jürgen Fripp, Kazuhiko Yanai, Nobuyuki Okamura and Christopher C. Rowe
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1560-1569; DOI: https://doi.org/10.2967/jnumed.121.263255
  • Basic

    • Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers
      You have access
      Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers
      Katherine L. Lucot, Marc Y. Stevens, T. Adam Bonham, E. Carmen Azevedo, Aisling M. Chaney, Ebony D. Webber, Poorva Jain, Jessica L. Klockow, Isaac M. Jackson, Mackenzie L. Carlson, Edward E. Graves, Thomas J. Montine and Michelle L. James
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1570-1578; DOI: https://doi.org/10.2967/jnumed.121.263039

Infectious Disease/Inflammation

  • Clinical

    • Total-Body <sup>18</sup>F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations
      You have access
      Total-Body 18F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations
      Yasser Abdelhafez, Siba P. Raychaudhuri, Dario Mazza, Soumajyoti Sarkar, Heather L. Hunt, Kristin McBride, Mike Nguyen, Denise T. Caudle, Benjamin A. Spencer, Negar Omidvari, Heejung Bang, Simon R. Cherry, Lorenzo Nardo, Ramsey D. Badawi and Abhijit J. Chaudhari
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1579-1585; DOI: https://doi.org/10.2967/jnumed.121.263774

Gastroenterology

  • Translational

    • FEATURED TRANSLATIONAL SCIENCE ARTICLE

      • PET Imaging of System x<sub>C</sub><sup>−</sup> in Immune Cells for Assessment of Disease Activity in Mice and Patients with Inflammatory Bowel Disease
        You have access
        PET Imaging of System xC− in Immune Cells for Assessment of Disease Activity in Mice and Patients with Inflammatory Bowel Disease
        Minjung Seo, Yeji Kim, Byong Duk Ye, Sang Hyoung Park, Seog-Young Kim, Jin Hwa Jung, Sung Wook Hwang, Sun Young Chae, Dong Yun Lee, Sang Ju Lee, Seung Jun Oh, Jihun Kim, Ji Young Kim, Sae Jung Na, Misung Kim, Sang-Yeob Kim, Norman Koglin, Andrew W. Stephens, Mi-Na Kweon and Dae Hyuk Moon
        Journal of Nuclear Medicine October 1, 2022, 63 (10) 1586-1591; DOI: https://doi.org/10.2967/jnumed.121.263289

Radiobiology/Dosimetry

  • Clinical

    • <sup>18</sup>F-FDG Fetal Dosimetry Calculated with PET/MRI
      You have access
      18F-FDG Fetal Dosimetry Calculated with PET/MRI
      Paolo Zanotti-Fregonara, Tatsuya Ishiguro, Kosuke Yoshihara, Shiro Ishii and Takayuki Enomoto
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1592-1597; DOI: https://doi.org/10.2967/jnumed.121.263561
    • <sup>68</sup>Ga-Citrate PET of Healthy Men: Whole-Body Biodistribution Kinetics and Radiation Dose Estimates
      You have access
      68Ga-Citrate PET of Healthy Men: Whole-Body Biodistribution Kinetics and Radiation Dose Estimates
      Sami Suilamo, Xiang-Guo Li, Petteri Lankinen, Vesa Oikonen, Tuula Tolvanen, Pauliina Luoto, Riikka Viitanen, Antti Saraste, Marko Seppänen, Laura Pirilä, Ulla Hohenthal and Anne Roivainen
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1598-1603; DOI: https://doi.org/10.2967/jnumed.122.263884

AI/Advanced Image Analysis

  • Clinical

    • Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging
      Open Access
      Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging
      Matthew G. Spangler-Bickell, Samuel A. Hurley, Ali Pirasteh, Scott B. Perlman, Timothy Deller and Alan B. McMillan
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1604-1610; DOI: https://doi.org/10.2967/jnumed.121.263309
    • Impact of ComBat Harmonization on PET Radiomics-Based Tissue Classification: A Dual-Center PET/MRI and PET/CT Study
      You have access
      Impact of ComBat Harmonization on PET Radiomics-Based Tissue Classification: A Dual-Center PET/MRI and PET/CT Study
      Doris Leithner, Heiko Schöder, Alexander Haug, H. Alberto Vargas, Peter Gibbs, Ida Häggström, Ivo Rausch, Michael Weber, Anton S. Becker, Jazmin Schwartz and Marius E. Mayerhoefer
      Journal of Nuclear Medicine October 1, 2022, 63 (10) 1611-1616; DOI: https://doi.org/10.2967/jnumed.121.263102

Departments

  • You have access
    Recruitment
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 15A;
  • You have access
    Erratum
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1597;

SNMMI Newsline

  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 13N-20N;
  • You have access
    ABNM CertLink: Update and “By the Numbers”
    Kirk A. Frey
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 13N;
  • You have access
    Making Nuclear Medicine a Household Phrase
    Munir Ghesani
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 14N;
  • You have access
    NewsBriefs
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 16N-17N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 18N-20N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 63 (10)
Journal of Nuclear Medicine
Vol. 63, Issue 10
October 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis
  • PET Imaging of System xC− in Immune Cells for Assessment of Disease Activity in Mice and Patients with Inflammatory Bowel Disease
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Hot Topics
  • Continuing Education
  • Focus on Molecular Imaging
  • Editorial
  • Theranostics
    • Clinical
      • INVITED PERSPECTIVE
      • BRIEF COMMUNICATION
      • FEATURED ARTICLE OF THE MONTH
  • Oncology
    • Clinical
  • Radionuclide Therapy
    • Clinical
  • Neurology
    • Clinical
    • Basic
  • Infectious Disease/Inflammation
    • Clinical
  • Gastroenterology
    • Translational
      • FEATURED TRANSLATIONAL SCIENCE ARTICLE
  • Radiobiology/Dosimetry
    • Clinical
  • AI/Advanced Image Analysis
    • Clinical
  • Departments
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire